Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study

被引：14
|
作者：
Antia, Camila [1 ]
Hone, Natalie [1 ]
Gloster, Hugh [1 ]
机构：
[1] Univ Cincinnati, Dept Dermatol, 231 Albert Sabin Way, Cincinnati, OH 45229 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 77卷 / 05期
关键词：
CUTANEOUS SURGERY;
D O I：
10.1016/j.jaad.2017.05.038
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：967 / 968
页数：2
相关论文
共 50 条
  • [1] Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery
    Heard, L. Kevin
    Shanahan, Christine
    Maggio, Kurt L.
    DERMATOLOGIC SURGERY, 2017, 43 (04) : 597 - 599
  • [2] Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery
    Chang, Timothy W.
    Arpey, Christopher J.
    Baum, Christian L.
    Brewer, Jerry D.
    Hochwalt, Phillip C.
    Hocker, Thomas L.
    Roenigk, Randall K.
    Otley, Clark C.
    DERMATOLOGIC SURGERY, 2015, 41 (07) : 784 - 793
  • [3] New anticoagulants: dabigatran, rivaroxaban and apixaban
    Vargas Ruiz, Angel Gabriel
    Ramirez Lopez, Alba Nydia
    Medina Viramontes, Monica Elizabeth
    GACETA MEDICA DE MEXICO, 2012, 148 (03): : 257 - 264
  • [4] Emergency surgery and trauma in patients treated with the new oral anticoagulants: Dabigatran, rivaroxaban, and apixaban
    Moorman, Matthew L.
    Nash, Joshua E.
    Stabi, Katie L.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 (03): : 486 - 494
  • [5] Novel Oral Anticoagulants in Development: Dabigatran, Rivaroxaban, and Apixaban
    Sattari, Maryam
    Lowenthal, David T.
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (04) : 332 - 338
  • [6] Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
    Steiner, T.
    Boehm, M.
    Dichgans, M.
    Diener, H. -C.
    Ell, C.
    Endres, M.
    Epple, C.
    Grond, M.
    Laufs, U.
    Nickenig, G.
    Riess, H.
    Roether, J.
    Schellinger, P. D.
    Spannagl, M.
    Veltkamp, R.
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (06) : 399 - 412
  • [7] Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
    T. Steiner
    M. Böhm
    M. Dichgans
    H.-C. Diener
    C. Ell
    M. Endres
    C. Epple
    M. Grond
    U. Laufs
    G. Nickenig
    H. Riess
    J. Röther
    P. D. Schellinger
    M. Spannagl
    R. Veltkamp
    Clinical Research in Cardiology, 2013, 102 : 399 - 412
  • [8] EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS DABIGATRAN, RIVAROXABAN AND APIXABAN
    Elnadoury, Ola
    Yuen, Meggie
    Oh, Erin
    Abraham, Teena
    Saad, Nasser
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [9] Postoperative Bleeding Complications Associated With Novel Oral Anticoagulants in Mohs Micrographic Surgery
    Fahmy, Lauren M.
    Dowd, Margaret L.
    Loesch, Eric
    Denson, Elizabeth M.
    Pisano, Catherine E.
    Samie, Faramarz H.
    DERMATOLOGIC SURGERY, 2024, 50 (01) : 1 - 4
  • [10] Rivaroxaban, dabigatran and apixaban. New anticoagulants in operative urology
    John, A.
    Michel, M. S.
    UROLOGE, 2014, 53 (06): : 893 - 902
12345